The global cranial implants market size was valued at USD 991.80 million in 2018 and is anticipated to expand at a CAGR of 6.4% by 2026. Increasing prevalence of neurological diseases, injuries, wounds, and road accidents coupled with rising awareness among professionals is anticipated to propel the growth.
Cranial implants or reconstruction is required for restoring the skull contour, protecting intracranial structures, and normalizing cerebral hemodynamics. Traditional methods of cranial reconstruction majorly focused on bone reconstruction and do not account for the soft tissues. If soft tissues are not addressed, they may lead to the deformity after surgeries. Technological advancements such as customized cranial implants and 3D printing help overcome the issues associated with the traditional methods.
Increasing road accidents and Traumatic Brain Injuries (TBI), among others are driving the market growth. For instance, according to the Centers for Disease Control and Prevention (CDC), in the U.S., around 2.8 million people suffer from TBI every year. It contributes to 30% of all the injury-related deaths in the U.S.
Increasing adoption of customized 3D printed and ceramic cranial implants are driving the market. Improving healthcare infrastructure and various government initiatives in the developing economies is also expected to positively influence growth of the market in the forthcoming years.
Customized cranial implants are extensively used for the treatment of defects such as craniosynostosis. It is a condition wherein, bones in the infants’ skulls grow prematurely leading to problems with the brain growth and shape of the head. If not treated, craniosynostosis can cause permanent brain damage. Rise in the prevalence of craniosynostosis is expected to impel the demand for customized cranial implants, thereby driving the market.
Customized cranial implants segment is expected to lead the market during the forecast period owing to the rising preference for the product by the surgeons as every skull injury is different and requires specific implants. Increasing prevalence of brain tumors owing to genetic disorders and unhealthy lifestyles coupled with increasing injuries, wounds, and road accidents are expected to drive the demand, thereby influencing the segment growth.
Manufacturers of customized cranial implants are focusing on collaborations with the surgeons to increase their customer base and to strengthen their market presence. Such initiatives coupled with the presence of well-established and skilled practitioners in developed economies is expected to further drive the demand.
Technology advancements, such as introduction of 3D printing with original multilayer technology is anticipated to offer lucrative opportunities. For instance, Stryker in collaboration with surgeon of Johns Hopkins Hospital developed host bone model made using 3D printing technology. This model helps orient the implant and allows the surgeons in planning the surgery before the actual operation.
Polymer material is expected to hold the maximum share of the cranial implants market over the forecast period. Polymer is the most frequently used material. It is provided as powder and liquid that are combined to fit into the contours of the cranial defects during the surgery.
Ceramic material segment is expected to register the highest CAGR during the forecast period. Application of light and sound to the brain have important therapeutic and diagnostic benefits. Ultrasound is the good therapy for the neurological diseases such as Alzheimer’s and Parkinson’s disease. However, material of cranial implants restricts the benefits. Ceramic cranial implant is able to transmit light and ultrasound to the brain. Thus, driving the market growth.
Neurosurgery centers is the fastest growing segment owing to the specialized and customized treatment of the patients. Furthermore, better outcome of results in comparison to hospitals is also increasing the demand for neurosurgery centers. In addition, neurosurgery centers ensure that the patients receive personalized treatment with improved patient experience.
Hospital is the leading segment due to the availability of skilled neurosurgeons and increasing disposable income of the individuals. Hospitals have neurological surgery departments with dedicated specialists. Mostly brain injuries, defects, and traumas require several treatment sessions, which is anticipated to propel the segment growth. Cranioplasty is one of major surgeries taking place in Neurosurgical Intensive Care Unit (NCCU). Also, improving healthcare infrastructure in developing countries and growing adoption of advanced products are expected to drive the growth.
North America accounted for the largest market share in 2018 and is expected to continue witnessing substantial growth in near future due to prevalence of trauma and brain cancer, adoption of technologically advanced products, and increasing healthcare spending by the regional governments.
Asia Pacific is expected to expand at the highest CAGR due to increasing cases of neurological disorders coupled with rise in government initiatives and awareness programs by the NGOs. Presence of a large number of industry players in economies, such as Japan, China, and India is majorly driving the growth. In addition, increasing cases of cancer is another key driver.
Major market players are B. Braun Melsungen AG; DePuy Synthes (Johnson and Johnson); Stryker Corporation; Zimmer Biomet; Osteomed; Synimed; Evonos; Medartis AG; Renishaw Plc; and Kelyiniam Global Inc. These players focus on entering into partnerships, new product launches, technological advancements, establishing new manufacturing centers and engaging in growth strategies, such as mergers and acquisitions for strengthening their market position.
Report Attribute |
Details |
Market size value in 2020 |
USD 1.12 billion |
Revenue forecast in 2026 |
USD 1.62 billion |
Growth Rate |
CAGR of 6.4% from 2019 to 2026 |
Base year for estimation |
2018 |
Historical data |
2015 - 2017 |
Forecast period |
2019 - 2026 |
Quantitative units |
Revenue in USD million and CAGR from 2019 to 2026 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, material, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Argentine; Colombia; South Africa; Saudi Arabia; UAE |
Key companies profiled |
B. Braun Melsungen AG; DePuy Synthes (Johnson and Johnson); Stryker Corporation; Zimmer Biomet; Osteomed; Synimed; Evonos; Medartis AG; Renishaw Plc; Kelyiniam Global Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global cranial implants market report on the basis of product, material type, end-use, and region:
Product Outlook (Revenue, 2015 - 2026 (USD Million))
Customized
Non-customized
Material Outlook (Revenue, 2015 - 2026 (USD Million))
Polymer
Ceramic
Metal
End-Use Outlook (Revenue, 2015 - 2026 (USD Million))
Hospital
Neurosurgery Centers
Regional Outlook (Revenue, 2015 - 2026 (USD Million))
North America
The U.S.
Canada
Europe
Germany
The U.K.
France
Italy
Spain
Asia Pacific
Japan
China
India
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Colombia
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
b. The global cranial implants market size was estimated at USD 1.05 billion in 2019 and is expected to reach USD 1.12 billion in 2020.
b. The global cranial implants market is expected to grow at a compound annual growth rate of 6.4% from 2019 to 2026 to reach USD 1.63 billion by 2026.
b. North America dominated the cranial implants market with a share of 37.92% in 2019. This is attributable to the increasing prevalence of trauma and brain cancer, adoption of technologically advanced products, and increasing healthcare spending by the regional governments.
b. Some of the key players operating in the cranial implants market include B. Braun Melsungen AG; DePuy Synthes (Johnson and Johnson); Stryker Corporation; Zimmer Biomet; Osteomed; Synimed; Evonos; Medartis AG; Renishaw Plc; and Kelyiniam Global Inc.
b. Key factors that are driving the market growth include increasing incidence of neurological diseases, high predominance of injury, wounds, road accidents, and increasing awareness among the population.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.